The development of primary malignant tumors is a distressing complication of organ transplant. However, the emergence of de novo renal cell carcinoma from a kidney allograft is rare. A 60-year-old man underwent living kidney transplant from a spousal donor. Six years after the transplant surgery, computed tomographic evaluation confirmed the presence of a 2.8-cm-diameter solid mass in the lower pole of the allograft. Partial allograft nephrectomy was performed, and the margin surrounding the normal parenchyma was resected. The serum level of creatinine did not decrease. Here, we report a case of renal cell carcinoma in an allograft kidney that was successfully treated with nephron-sparing surgery.
Get full access to this article
View all access options for this article.
References
1.
RoupretMPeraldiMNThaunatO. Renal cell carcinoma of the grafted kidney: How to improve screening and graft trackingTransplantation.2004;77:146–148.
2.
PennI. Occurrence of cancer in immunosuppressed organ transplant recipientsClin Transplant.1998;69:147–158.
3.
WunedrlichHWilhelmSReicheltOZermannDHBörnerRSchubertJ. Renal cell carcinoma in renal graft recipients and donors: Incidence and consequenceUrol Int.2001;67:24–27.
4.
PloussardGChambadeDMeriaP. Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: A single-centre management experience in a 2396 recipient cohort. BJU Int.2012;109:195–199.
5.
TillouXDoerflerACollonS. De novo kidney graft tumors: Results from a multicentric retrospective national studyAm J Transplant.2012;12:3308–3315.
6.
BarrettWLFirstMRAronBSPennI. Clinical course of malignancies in renal transplant recipientsCancer.1993;72:2186–2189.
7.
NeuzilletYLayFLuccioniA. De novo renal cell carcinoma of native kidney in renal transplant recipientsCancer.2005;103:251–257.
8.
CoxANguanCYLukePP. Partial nephrectomy for renal cell carcinoma in long-term renal allografts: Operative and postoperative considerationsCan J Urol.2005;12:2887–2890.
9.
CornelisFBuyXAndréM. De novo renal tumors arising in kidney transplants: Midterm outcome after percutaneous thermal ablationRadiology.2011;260:900–907.
10.
GoemanLJoniauSOyenRVan PoppelH. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomyUrology.2006;67:199.
11.
HodaMRHamzaAWagnerSGrecoFFornaraP. Recurrence of renal cell carcinoma in a renal allograft after partial transplant nephrectomy: A case reportUrol Int.2009;83:239–241.
12.
LambGWABaxterGMRodgerRSCAitchisonM. Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidneyUrol Res.2004;32:89–92.
13.
KrishnamurthiVNovickAC. Nephron-sparing surgery in a renal allograftUrology.1997;50:132–134.
14.
ShingletonWBSewellPE. Percutaneous cryoablation of renal cell carcinoma in a transplanted kidneyBJU Int.2002;90:137–138.
15.
NakaiSIsekiKItamiN. Overview of regular dialysis treatment in Japan (as of 31 December 2010)Ther Apher Dial.2012;16:483–521.
SuMZCampbellNALauHM. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unitTransplantation.2014;97(6):654–659.
18.
FeldmanJDJacobsSC. Late development of renal carcinoma in allograft kidneyJ Urol.1992;148:395–397.
McHaylehWMorcosJPWuT. Renal cell carcinoma from a transplanted allograft: Two case reports and a review of the literatureClin Genitourin Cancer.2008;6:53–55.
21.
TremblayFFernandesMHabbabFde B EdwardesMDLoertscherRMeterissianS. Malignancy after renal transplantation: Incidence and role of type of immunosuppressionAnn Surg Oncol.2002;9:785–788.
22.
GeisslerEKSchlittHJ. The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantationKidney Int.2010;78:1075–7079.
23.
KauffmanHMCherikhWSChengYHantoDWKahanBD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignanciesTransplantation.2005;80:883–889.
24.
NakajimaIIwafujiKOkamotoMKitadaHNagiK. Malignancies after transplantation [in Japanese] Transplantation Now.2012;25:323–352.
25.
KasiskeBLSnyderJJGilbertsonDTWangC. Cancer after kidney transplantation in the United StatesAm J Transplant.2004;4:905–913.
26.
DonatSMDiazMBishoffJT. Follow-up for clinically localized renal neoplasms: AUA GuidelineJ Urol.2013;190:407–416.
